Skip to main content
. 2016 Jun 7;311(1):E252–E259. doi: 10.1152/ajpendo.00082.2016

Fig. 3.

Fig. 3.

Plasma glucagon-like peptide-1 (GLP-1) concentrations following enteral or iv administration of glucose. A: gastric and jejunal administrations of glucose. B: gastric and isoglycemic iv administrations of glucose. C: jejunal and isoglycemic iv administrations of glucose. D: AUCs for enteral administrations of glucose and the corresponding isoglycemic iv glucose matches. **P ≤ 0.01; ***P ≤ 0.001.